Leaflet KANAMICINA H 5mg / 10mg / g ophthalmic ointment


Indicated for: bacterial infections

Substance: kanamycin + hydrocortisone (aminoglycoside antibiotic + glucocorticoid)

ATC: S01CA03 (Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination)

The combination of kanamycin and hydrocortisone is used to treat local bacterial infections associated with severe inflammation. Kanamycin acts as an antibiotic, killing bacteria, while hydrocortisone is a corticosteroid that reduces inflammation and associated symptoms such as pain and swelling.

The medication is available as creams, ointments, or solutions and is applied locally as directed by a doctor.

Side effects may include local irritation, allergic reactions, or, in rare cases, systemic absorption of the corticosteroid, leading to systemic adverse effects.

Patients should strictly follow usage instructions and avoid applying it to open wounds or large skin areas. Pregnant or breastfeeding women should consult a specialist before use.

General data about KANAMICINA H 5mg / 10mg / g

  • Substance: kanamycin + hydrocortisone
  • Date of last drug list: 01-05-2026
  • Commercial code: W41625001
  • Concentration: 5mg / 10mg / g
  • Pharmaceutical form: ophthalmic ointment
  • Quantity: 1
  • Product type: generic
  • Price: 25.26 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 12272/2019/01
  • Shelf life: 3 years-after packing for marketing;after the first opening of the tube - 15 days